Back

A scalable screening platform for discovering predominant miRNA target genes and druggable siRNA sequences

Kong, J.; Leung, S. S. K.; Lau, C. F.; Mok, B. W.-Y.; Weng, M.; Jauch, R.; Chen, H.; Kwon, S. C.

2025-11-17 molecular biology
10.1101/2025.11.17.688664 bioRxiv
Show abstract

Animal microRNAs primarily regulate their targets through seed pairing. However, the contributions of non-seed regions and the identity of predominant targets in specific contexts remain poorly defined. We developed shRNAone, an shRNA design that produces highly homogeneous small RNAs and more closely mimics endogenous miRNA biogenesis. Using shRNAone, we built SynthoMir, a comprehensive human miRNA variant library enabling high-throughput dissection of miRNA features beyond the seed region. Applying this platform, we show that miR-494 regulates ISCA1 via 3 supplementary pairing, and that ISCA1 is the predominant target mediating miR-494-associated sorafenib resistance in hepatocellular carcinoma. We further leveraged shRNAones homogeneity in pooled tiling screens to map druggable RNAi target sites in TTR and PCSK9, two targets of FDA-approved siRNA therapeutics. Our findings indicate that the outputs from shRNAone screening can be readily translated into effective siRNA designs. Together, shRNAone provides a versatile platform for dissecting miRNA regulatory networks and guiding the design of therapeutic siRNA sequences.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.